It is a healthcare private limited company based in Borivali East, Maharashtra, India, established in 2010.
2010 | Borivali East, Maharashtra, India | ActiveSafron Pharmaceuticals Private Limited, a active private limited company, was established on 08 December 2010 in Borivali East, Maharashtra, India. Engaging in preventive health services within the manufacturing sector, it holds CIN: U85100MH2010PTC210796. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Manish Mittal (Director), Sanju Vijay (Director), Mahesh Chand Gupta (Director). Past directors included Manish Mittal, Mukesh Kumar Gupta, Rohit Singhal. It holds ₹4.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No 12, Kavita Bldg, Main Carter Road Next To Icici Bank, Borivali East, Maharashtra, 400066.
U85100MH2010PTC210796
210796
08 December 2010
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Safron Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manish Mittal | Director | 18 Jul 2013 | Current |
| Sanju Vijay | Director | 08 Dec 2010 | Current |
| Mahesh Chand Gupta | Director | 08 Dec 2010 | Current |
| Mukesh Kumar Gupta | Director | 07 Aug 2015 | Current |
| Rohit Singhal | Director | 06 Jan 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 28 Sep 2013 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Safron Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.66% increase. The company also saw a substantial improvement in profitability, with a 112.24% increase in profit. The company's net worth moved up by a moderate rise of 1.89%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Safron Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Oct 2017 | Others | ₹4.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Safron Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Safron Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Safron Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Safron Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Safron Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on A charge with Others amounted to Rs. 4.00 M with Charge ID 100133005 was registered on 31 Oct 2017. was documented.
Mukesh Kumar Gupta was appointed as a Director was appointed as a Director on 07 Aug 2015 & has been associated with this company since 10 years 4 months . was recorded as a recent event.
The activity Rohit Singhal was appointed as a Director was appointed as a Director on 06 Jan 2014 & has been associated with this company since 11 years 11 months . was completed.
Manish Mittal was appointed as a Director was appointed as a Director on 18 Jul 2013 & has been associated with this company since 12 years 5 months . was recorded as a recent event.
The CIN of Safron Pharmaceuticals Private Limited is U85100MH2010PTC210796.
Safron Pharmaceuticals Private Limited is headquartered at Shop No 12, Kavita Bldg, Main Carter Road Next To Icici Bank, Borivali East, Maharashtra, 400066.
Safron Pharmaceuticals Private Limited was incorporated on 08 December 2010.
The current directors of Safron Pharmaceuticals Private Limited are
The primary industry of Safron Pharmaceuticals Private Limited is Manufacturing.
Safron Pharmaceuticals Private Limited is unlisted.
The authorized capital of Safron Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Safron Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX